Physician profile
Matthew E Morris
NPI 1073744900
$4,623.78
in general payments reported to CMS, 2019-2025
15 companies · $710 in 2025
The $710 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $73.88 · 2021: $721 · 2022: $836 · 2023: $534 · 2024: $910 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,854 · Entertainment: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,854.21 |
| Entertainment | $299.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,454.80 | 2021-2025 | Total30, Precision 1, Dailies |
| Coopervision INC. | $1,123.50 | 2019-2024 | Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $526.51 | 2019-2025 | Acuvue |
| Optos, INC. | $482.51 | 2021-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $320.24 | 2022-2025 | Infuse, Biotrue One Day, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $199.09 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $142.84 | 2021 | |
| Sight Sciences, INC. | $126.55 | 2025 | Tearcare System |
| Abb Con-Cise Optical Group LLC | $68.68 | 2024 | Spectacle Lenses, Contact Lens |
| Allergan, INC. | $67.41 | 2022 | |
| Lkc Technologies, INC. | $31.70 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $23.63 | 2025 | Xdemvy |
| Rxsight INC | $22.28 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Harrow Eye, LLC | $17.13 | 2024 | Vevye |
| Abbvie INC. | $16.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.